V. Préat

发表

PLGA based drug delivery systems: Promising carriers for wound healing activity

K. K. Chereddy, G. Vandermeulen, V. Préat, 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Topical Gene Transfer into Rat Skin Using Electroporation

Véronique Préat, Nathalie Dujardin, V. Préat, 2004, Pharmaceutical Research.

Bioadhesive nanoparticles of fungal chitosan for oral DNA delivery.

G. Vandermeulen, V. Préat, L. Plapied, 2010, International journal of pharmaceutics.

Copolymers of ε-caprolactone and quaternized ε-caprolactone as gene carriers

V. Préat, R. Jerome, B. Vroman, 2007 .

Copolymers of epsilon-caprolactone and quaternized epsilon-caprolactone as gene carriers.

V. Préat, R. Jerome, B. Vroman, 2007, Journal of controlled release : official journal of the Controlled Release Society.

PEGylated quaternized copolymer/DNA complexes for gene delivery.

V. Préat, C. Jérôme, R. Jerome, 2007, International journal of pharmaceutics.

Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight.

Kevin Vanvarenberg, Caroline Bouzin, Héloïse Ragelle, 2015, Journal of controlled release : official journal of the Controlled Release Society.

DNA electrotransfer into the skin using a combination of one high- and one low-voltage pulse.

N. Pavselj, V. Préat, V Préat, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Transdermal Delivery of Macromolecules Using Skin Electroporation

Véronique Préat, Nathalie Dujardin, V. Préat, 2004, Pharmaceutical Research.

Skin electroporation for transdermal and topical delivery.

Véronique Préat, V. Préat, A. Denet, 2004, Advanced drug delivery reviews.

Recent Advances in Skin Electroporation: Mechanism and Efficacy

J. Weaver, M. Prausnitz, T. Gowrishankar, 1999 .

Comparison of Iontophoresis and Electroporation: Mechanisms and Tolerance

V. Préat, R. Vanbever, A. Jadoul, 1999 .

Comparison of the effects of short, high-voltage and long, medium-voltage pulses on skin electrical and transport properties.

J. Weaver, V. Préat, U. Pliquett, 1999, Journal of controlled release : official journal of the Controlled Release Society.

Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems.

Christel A. S. Bergström, M. Brandl, M. Kuentz, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Chitosan and chitosan derivatives in drug delivery and tissue engineering

V. Préat, C. Jérôme, R. Riva, 2011 .

RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis.

V. Préat, F. Danhier, A. Le Breton, 2012, Molecular pharmaceutics.

PLGA-based nanoparticles: an overview of biomedical applications.

V. Préat, F. Danhier, A. Le Breton, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance.

V. Préat, C. Lombry, R. Vanbever, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging.

S. Laurent, R. Muller, V. Préat, 2013, International journal of pharmaceutics.

Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia☆

V. Préat, S. Izui, L. Detalle, 2004, Autoimmunity Reviews.

Distinct Host-Dependent Pathogenic Mechanisms Leading to a Similar Clinical Anemia After Infection with Lymphocytic Choriomeningitis Virus

V. Préat, C. Pfau, M. Day, 2005, Experimental biology and medicine.

Modeling of the burst release from PLGA micro- and nanoparticles as function of physicochemical parameters and formulation characteristics.

Rui Oliveira, Véronique Préat, Moritz von Stosch, 2017, International journal of pharmaceutics.

Development of a liquid chromatographic method for the simultaneous quantification of curcumin, β-arteether, tetrahydrocurcumin and dihydroartemisinin. Application to lipid-based formulations.

R. Marini, P. Hubert, E. Rozet, 2014, Journal of pharmaceutical and biomedical analysis.

Improvement of the decision efficiency of the accuracy profile by means of a desirability function for analytical methods validation. Application to a diacetyl-monoxime colorimetric assay used for the determination of urea in transdermal iontophoretic extracts.

P. Hubert, E. Rozet, V. Préat, 2007, Analytica chimica acta.

Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection

V. Préat, G. Bastiat, K. Vanvarenberg, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Dual paclitaxel/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging

S. Laurent, R. Muller, V. Préat, 2012 .

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.

Véronique Préat, Fabienne Danhier, O. Feron, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Surface Modification of Lipid-Based Nanoparticles.

V. Préat, A. des Rieux, A. Beloqui, 2022, ACS nano.

High‐throughput assessment of antigen conformational stability by ultraviolet absorption spectroscopy and its application to excipient screening

Dominique Lemoine, Véronique Préat, Sébastien Dasnoy, 2012, Biotechnology and bioengineering.

Clinical potential of electroporation for gene therapy and DNA vaccine delivery

Laure Lambricht, Gregor Sersa, Gaëlle Vandermeulen, 2016, Expert opinion on drug delivery.

Nanomedicines and gene therapy for the delivery of growth factors to improve perfusion and oxygenation in wound healing

V. Préat, B. Gallez, C. Desmet, 2018, Advanced drug delivery reviews.

PLGA nanoparticles loaded with host defense peptide LL37 promote wound healing.

K. K. Chereddy, G. Vandermeulen, V. Préat, 2014, Journal of controlled release : official journal of the Controlled Release Society.

In vitro investigations of smart drug delivery systems based on redox-sensitive cross-linked micelles.

V. Préat, C. Jérôme, S. Cajot, 2013, Macromolecular bioscience.

Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles.

Christine Jérôme, Véronique Préat, Jacqueline Marchand-Brynaert, 2012, Methods in enzymology.

Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621.

M. Brewster, V. Préat, F. Danhier, 2010, International journal of pharmaceutics.

Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.

Christine Jérôme, Véronique Préat, Jacqueline Marchand-Brynaert, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma

V. Préat, F. Danhier, B. Ucakar, 2018, International journal of nanomedicine.

PEG‐PGA enveloped octaarginine‐peptide nanocomplexes: An oral peptide delivery strategy

M. J. Santander-Ortega, E. Giralt, V. Préat, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Polymer-Based Nanoparticles as Modern Vaccine Delivery Systems

G. Vandermeulen, V. Préat, Laure Lambricht, 2017 .

Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.

V. Préat, A. des Rieux, A. Beloqui, 2014, International journal of pharmaceutics.

Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.

V. Préat, A. des Rieux, A. Beloqui, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Development of PLGA-mannosamine nanoparticles as oral protein carriers.

M. Alonso-Sande, V. Préat, B. Sarmento, 2013, Biomacromolecules.

Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium.

P. Artursson, Y. Schneider, V. Préat, 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

Yves-Jacques Schneider, Véronique Préat, Y. Schneider, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Fate of polymeric nanocarriers for oral drug delivery

V. Préat, L. Plapied, A. D. Rieux, 2011 .

3D systems delivering VEGF to promote angiogenesis for tissue engineering.

P. Carmeliet, O. Feron, V. Préat, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats.

V. Préat, R. Vanbever, C. Bosquillon, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1-34) from rat lungs.

V. Préat, R. Vanbever, F. Vanderbist, 2004, Journal of pharmaceutical sciences.

In Vitro Lipolysis and Intestinal Transport of β-Arteether-Loaded Lipid-Based Drug Delivery Systems

E. Gaigneaux, V. Préat, P. Eloy, 2013, Pharmaceutical Research.

Fluorescent Labeling of Degradable Poly(Lactide-Co-Glycolide) for Cellular Nanoparticles Tracking in Living Cells

V. Préat, C. Jérôme, P. Lecomte, 2011, The International journal of artificial organs.

Characterization of self-assembling copolymers in aqueous solutions using Electron Paramagnetic Resonance and Fluorescence spectroscopy.

M. Brewster, V. Préat, B. Gallez, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the Current Applications and Challenges in Oral Drug Delivery

V. Préat, A. Beloqui, P. Memvanga, 2020, Pharmaceutics.

In vivo Noninvasive Evaluation of Hairless Rat Skin after High-Voltage Pulse Exposure

V. Préat, R. Vanbever, A. Jadoul, 1998, Skin Pharmacology and Physiology.

Quality-by-Design-Based Development of a Voxelotor Self-Nanoemulsifying Drug-Delivery System with Improved Biopharmaceutical Attributes

V. Préat, A. Beloqui, J. K. Mbinze, 2021, Pharmaceutics.

Chitosan Nanoparticles for SiRNA Delivery In Vitro.

G. Vandermeulen, V. Préat, H. Ragelle, 2016, Methods in molecular biology.

Combined effects of PLGA and vascular endothelial growth factor promote the healing of non-diabetic and diabetic wounds.

P. Carmeliet, K. K. Chereddy, G. Vandermeulen, 2015, Nanomedicine : nanotechnology, biology, and medicine.

Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery

L. Tenenbaum, V. Préat, C. Bruyns, 2011, Cancer Immunology, Immunotherapy.

pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.

V. Préat, A. des Rieux, A. Beloqui, 2014, International journal of pharmaceutics.

Drug delivery to inflamed colon by nanoparticles: comparison of different strategies.

David J Brayden, Y. Schneider, V. Préat, 2013, International journal of pharmaceutics.

Nano-emulsions of fluorinated trityl radicals as sensors for EPR oximetry.

K. Amighi, V. Préat, N. Wauthoz, 2009, Journal of magnetic resonance.

Prediction of drug solubility in amphiphilic di-block copolymer micelles: the role of polymer-drug compatibility.

M. Brewster, V. Préat, L. Rouxhet, 2007, Die Pharmazie.

Highly potent delivery method of gp160 envelope vaccine combining lentivirus-like particles and DNA electrotransfer.

G. Dickson, G. Vandermeulen, V. Préat, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease.

V. Préat, A. Beloqui, G. Muccioli, 2016, International journal of pharmaceutics.

Local and Systemic Immune Responses to Intratracheal Instillation of Antigen and DNA Vaccines in Mice

J. Renauld, D. Lison, V. Préat, 2004, Pharmaceutical Research.

Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.

D. Arango, R. Satchi‐Fainaro, V. Préat, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.

W. Jiskoot, Y. Schneider, V. Préat, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.

M. Roberfroid, V. Préat, H. Taper, 1986, Japanese journal of cancer research : Gann.

Comparison of Different Models of Rat Liver Carcinogenesis: Conclusions from a Systemic Analysis

M. Roberfroid, V. Préat, H. Taper, 1984, Toxicologic pathology.

Targeted nanoparticles with novel non-peptidic ligands for oral delivery.

Patrice D Cani, J. Marchand-Brynaert, V. Préat, 2013, Advanced drug delivery reviews.

Vitamin E-based nanomedicines for anti-cancer drug delivery.

V. Préat, Nicolas Duhem, F. Danhier, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Combined effect of PLGA and curcumin on wound healing activity.

K. K. Chereddy, G. Vandermeulen, V. Préat, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles.

M. Brewster, G. Vandermeulen, V. Préat, 2006, International journal of pharmaceutics.

Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani.

F. Opperdoes, V. Préat, R. Gaspar, 1992, Annals of tropical medicine and parasitology.

An oral malaria therapy: curcumin-loaded lipid-based drug delivery systems combined with β-arteether.

V. Préat, R. Coco, P. Memvanga, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Formulation design and in vivo antimalarial evaluation of lipid-based drug delivery systems for oral delivery of β-arteether.

V. Préat, P. Memvanga, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Photosensitizer localization in amphiphilic block copolymers controls photodynamic therapy efficacy.

N. McClenaghan, V. Préat, J. Guigner, 2017, Nanoscale.

Optimized acriflavine‐loaded lipid nanocapsules as a safe and effective delivery system to treat breast cancer

B. Krishnamachary, O. Feron, Z. Bhujwalla, 2018, International journal of pharmaceutics.

Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes

V. Préat, N. Csaba, Lungile Nomcebo Thwala, 2017, Expert opinion on drug delivery.

PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination.

Y. Schneider, J. Marchand-Brynaert, V. Préat, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Development of functionalized nanoparticles for vaccine delivery to dendritic cells: a mechanistic approach.

Liana C. Silva, V. Oliveira, G. Vandermeulen, 2014, Nanomedicine.

New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models

G. Vandermeulen, V. Préat, K. Vanvarenberg, 2021, Journal for ImmunoTherapy of Cancer.

Electrically enhanced transdermal delivery of domperidone

V. Préat, A. Jadoul, 1997 .

Electroporation-mediated delivery of 3'-protected phosphodiester oligodeoxynucleotides to the skin.

V. Préat, V. Regnier, A. Tahiri, 2000, Journal of controlled release : official journal of the Controlled Release Society.

Mechanisms of a Phosphorothioate Oligonucleotide Delivery by Skin Electroporation

V. Préat, A. Jadoul, V. Regnier, 1998 .

Parameters controlling topical delivery of oligonucleotides by electroporation.

V. Préat, V. Regnier, T. Le Doan, 1998, Journal of drug targeting.

In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.

F. Mollinedo, V. Préat, A. Estella-Hermoso de Mendoza, 2011, Journal of controlled release : official journal of the Controlled Release Society.

A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation

David J Brayden, P. Artursson, V. Préat, 2017, Nature Protocols.

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model

G. Vandermeulen, V. Préat, K. Vanvarenberg, 2022, Pharmaceutics.

Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats.

D. Lison, V. Préat, R. Vanbever, 2003, Journal of pharmaceutical sciences.

Assessment of the “Skin Reservoir” of Urea by Confocal Raman Microspectroscopy and Reverse Iontophoresis in vivo

R. Guy, M. Jadoul, V. Préat, 2007, Pharmaceutical Research.

Non-invasive diagnosis and monitoring of chronic kidney disease by reverse iontophoresis of urea in vivo.

R. Guy, M. Jadoul, P. Hubert, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

PCL-PEG-based nanoparticles grafted with GRGDS peptide: preparation and surface analysis by XPS.

J. Marchand-Brynaert, V. Préat, V. Pourcelle, 2007, Biomacromolecules.

The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach.

V. Préat, M. Alonso, S. Tovar, 2016, Journal of controlled release : official journal of the Controlled Release Society.

A Mechanistic Study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) Secretion from Enteroendocrine L Cells.

Patrice D Cani, V. Préat, K. Vanvarenberg, 2016, Molecular pharmaceutics.

Monitoring of Urea and Potassium by Reverse Iontophoresis In Vitro

R. Guy, M. Delgado-Charro, P. Hubert, 2007, Pharmaceutical Research.

Gene electrotransfer into skin using noninvasive multi-electrode array for vaccination and wound healing.

G. Vandermeulen, V. Préat, M. Čemažar, 2017, Bioelectrochemistry.

Electrotransfer parameters as a tool for controlled and targeted gene expression in skin

G. Vandermeulen, V. Préat, L. Prosen, 2016, Molecular therapy. Nucleic acids.

Impact of PEGylation on antibody-loaded nanoparticulate drug delivery system on treatment of inflammatory bowel disease.

David J Brayden, V. Préat, A. Beloqui, 2021, Acta biomaterialia.

Helodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicle-associated epithelium.

M. Alonso-Sande, Y. Schneider, V. Préat, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Vitamin E-based micelles enhance the anticancer activity of doxorubicin.

O. Feron, V. Préat, Nicolas Duhem, 2014, International journal of pharmaceutics.

Monoglyceride-based self-assembling copolymers as carriers for poorly water-soluble drugs.

J. Rosenblatt, M. Brewster, V. Préat, 2009, International journal of pharmaceutics.

NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo.

V. Préat, A. des Rieux, P. Saulnier, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Confocal imaging of rat lungs following intratracheal delivery of dry powders or solutions of fluorescent probes.

V. Préat, C. Lombry, R. Vanbever, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site

V. Cerullo, G. Vandermeulen, V. Préat, 2019, Journal of Immunotherapy for Cancer.

Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination.

Y. Schneider, J. Marchand-Brynaert, V. Préat, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Fibrin hydrogels to deliver dental stem cells of the apical papilla for regenerative medicine.

C. Dupont-Gillain, G. Vandermeulen, V. Préat, 2015, Regenerative medicine.

Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat

David J Brayden, P. Artursson, P. Hellström, 2022, ACS nano.

Effect of Tape Stripping and Adjuvants on Immune Response After Intradermal DNA Electroporation

G. Vandermeulen, V. Préat, B. Ucakar, 2009, Pharmaceutical Research.

Skin-specific promoters for genetic immunisation by DNA electroporation.

D. Scherman, G. Vandermeulen, V. Préat, 2009, Vaccine.

In Situ Hybridization of Ha-RAS during Rat Liver Carcinogenesis

M. Roberfroid, V. Préat, Y. Nizet, 1991 .

Antimicrobial peptide-gold nanoscale therapeutic formulation with high skin regenerative potential.

K. K. Chereddy, V. Préat, S. Pinto, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment.

K. Braeckmans, Patrice D Cani, V. Préat, 2020, Biomaterials.

Size Effect on Lipid Nanocapsule-Mediated GLP-1 Secretion from Enteroendocrine L Cells.

Patrice D Cani, V. Préat, A. Beloqui, 2018, Molecular pharmaceutics.

EPR monitoring of wound oxygenation as a biomarker of response to gene therapy encoding hCAP‐18/LL37 peptide

G. Vandermeulen, V. Préat, C. Bouzin, 2018, Magnetic resonance in medicine.

Molecular Transport across Stratum Corneum due to Electric Pulses:Behavior of Localized Transport Regions (LTRS)

G. T. Martin, J. Weaver, V. Préat, 1999 .

Transdermal alniditan delivery by skin electroporation.

V. Préat, A. Jadoul, N. Lecouturier, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Transdermal permeation of neutral molecules by skin electroporation.

V. Préat, R. Vanbever, M. LeRoy, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Skin Electroporation for Transdermal Drug Delivery

J. Weaver, V. Préat, R. Vanbever, 1999 .

Quantification and localization of fentanyl and trh delivered by iontophoresis in the skin

V. Préat, A. Jadoul, S. Thysman, 1995 .

Modifications induced on stratum corneum structure after in vitro iontophoresis: ATR-FTIR and X-ray scattering studies

D. Durand, V. Préat, A. Jadoul, 1996 .

Human Calcitonin Delivery in Rats by Iontophoresis

V. Préat, S. Thysman, Cecile Hanchard, 1994, The Journal of pharmacy and pharmacology.

Endoglin (CD105) Silencing Mediated by shRNA Under the Control of Endothelin-1 Promoter for Targeted Gene Therapy of Melanoma.

G. Vandermeulen, V. Préat, B. Turk, 2015, Molecular therapy. Nucleic acids.

Delivery of soluble VEGF receptor 1 (sFlt1) by gene electrotransfer as a new antiangiogenic cancer therapy.

O. Feron, C. Dessy, J. Verrax, 2011, Molecular pharmaceutics.

The origin of neural stem cells impacts their interactions with targeted‐lipid nanocapsules: Potential role of plasma membrane lipid composition and fluidity

V. Préat, A. des Rieux, M. Mingeot-Leclercq, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Nanoparticles of Polyisohexylcyanoacrylate (pihca) As Carriers of Primaquine - Formulation, Physicochemical Characterization and Acute Toxicity

V. Préat, R. Gaspar, M. Roland, 1991 .

PEG-polyaminoacid based micelles for controlled release of doxorubicin: Rational design, safety and efficacy study.

P. Caliceti, C. Alexander, V. Préat, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells.

V. Préat, C. Bastiancich, G. Muccioli, 2022, International journal of pharmaceutics.

Nasal vaccines. From fundamental concepts to vaccine development

V. Préat, D. Lemoine, M. Francotte, 1998 .

Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.

U. Schubert, J. Marchand-Brynaert, V. Préat, 2014, Bioconjugate chemistry.

Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.

V. Préat, A. Beloqui, R. Coco, 2013, International journal of pharmaceutics.

Combinational Drug-Loaded Lipid Nanocapsules for the Treatment of Cancer.

V. Préat, Arnaud M. Vigneron, Alessandra Lopes, 2019, International journal of pharmaceutics.

Mechanisms of Antigen Adsorption Onto an Aluminum-Hydroxide Adjuvant Evaluated by High-Throughput Screening.

V. Préat, D. Lemoine, Nicolas Moniotte, 2016, Journal of pharmaceutical sciences.

A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease.

V. Préat, M. de la Fuente, M. Alonso, 2016, Colloids and surfaces. B, Biointerfaces.

How Can Intracellular Full-Length siRNA Quantification Help in the Study of Carrier-Mediated Delivery In Vitro ?

H. M. Nielsen, V. Préat, H. Ragelle, 2012 .

Synthesis and In Vitro Evaluation of Polyethylene Glycol-Paclitaxel Conjugates for Lung Cancer Therapy

C. Alexander, V. Préat, R. Vanbever, 2016, Pharmaceutical Research.

Inhibition of colorectal cancer-associated fibroblasts by lipid nanocapsules loaded with acriflavine or paclitaxel.

O. Feron, V. Préat, Thibaut Fourniols, 2020, International journal of pharmaceutics.

Preparation and characterization of alginate microspheres containing a model antigen

V. Préat, D. Lemoine, F. Wauters, 1998 .

Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin.

M. Roberfroid, V. Préat, J. Vamecq, 1990, Carcinogenesis.

Elaboration of drug nanocarriers based on a glucosamine labeled amphiphilic polymer

V. Préat, C. Jérôme, R. Riva, 2014 .

Development of a high-throughput screening platform to study the adsorption of antigens onto aluminum-containing adjuvants.

V. Préat, D. Lemoine, Nicolas Moniotte, 2015, Journal of pharmaceutical sciences.

Delivery of Peptides Via the Oral Route: Diabetes Treatment by Peptide-Loaded Nanoparticles.

V. Préat, A. Beloqui, Oriane Bouttefeux, 2016, Current pharmaceutical design.

Nanoparticle transport across in vitro olfactory cell monolayers.

V. Préat, J. Pedraz, A. Beloqui, 2016, International journal of pharmaceutics.

Nanostructured lipid carriers: Promising drug delivery systems for future clinics.

V. Préat, A. Almeida, A. Beloqui, 2016, Nanomedicine : nanotechnology, biology, and medicine.

Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury.

V. Préat, L. Shea, A. des Rieux, 2011, Journal of biomedical materials research. Part A.

Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules.

Véronique Préat, V. Préat, C. Lombry, 2004, American journal of physiology. Lung cellular and molecular physiology.

Synergistic effect of doxorubicin lauroyl hydrazone derivative delivered by α-tocopherol succinate micelles for the treatment of glioblastoma

V. Préat, C. Bastiancich, Mingchao Wang, 2022, International journal of pharmaceutics: X.

Aerosolization properties, surface composition and physical state of spray-dried protein powders.

P. Rouxhet, V. Préat, R. Vanbever, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Solid lipid Nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide?

V. Préat, H. Fessi, A. Beloqui, 2020, International journal of pharmaceutics.

In vitro percutaneous penetration through hairless rat skin: influence of temperature, vehicle and penetration enhancers.

K. Alewaeters, P. Clarys, A. Barel, 1998, European journal of pharmaceutics and biopharmaceutics.

A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin

M. J. Santander-Ortega, V. Préat, B. Sarmento, 2021, Drug Delivery and Translational Research.

In Vivo Methods for the Assessment of Topical Drug Bioavailability

Véronique Préat, Aarti Naik, Richard H. Guy, 2007, Pharmaceutical Research.

Transdermal iontophoretic delivery of sufentanil

V. Préat, S. Thysman, 1993 .

Effect of polyoxyethyleneglycol (24) cholesterol on the solubility, toxicity and activity of amphotericin B.

V. Préat, M. Roland, F. Goethals, 1990 .

On-line determination of fluconazole in blood and dermal rat microdialysates by microbore high-performance liquid chromatography.

V. Préat, B. Vroman, A. De Winne, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Comparison of nephrotoxicities of different polyoxyethyleneglycol formulations of amphotericin B in rats

V. Préat, M. Roland, C. Tasset, 1992, Antimicrobial Agents and Chemotherapy.

Fluconazole distribution in rat dermis following intravenous and topical application: a microdialysis study.

V. Préat, R. Verbeeck, F. Mathy, 2005, Journal of pharmaceutical sciences.

The Influence of Myrj 59 on the Solubility, Toxicity and Activity of Amphotericin B

V. Préat, M. Roland, C. Tasset, 1991, The Journal of pharmacy and pharmacology.

The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator.

M Roberfroid, M. Roberfroid, V. Préat, 1991, Toxicology and applied pharmacology.

On the mechanism of the hepatocarcinogenicity of peroxisome proliferators.

B Beije, C Ramel, V. Préat, 1991, Chemico-biological interactions.

Comparison of the in vivo antifungal activity of amphotericin B-Solulan C24, amphotericin B-Myrj 59 and amphotericin B-Synperonic A50 with fungizone

V. Préat, M. Roland, C. Tasset, 1992 .

Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems.

V. Préat, A. Beloqui, N. Shrestha, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors.

V. Préat, A. des Rieux, F. Danhier, 2015, International journal of pharmaceutics.

Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies

V. Préat, Y. Larondelle, C. Andre, 2017, Molecules.

Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.

K. Braeckmans, B. Nysten, G. Vandermeulen, 2014, Journal of controlled release : official journal of the Controlled Release Society.

A self-healable, moldable and bioactive biomaterial gum for personalised and wearable drug delivery.

Véronique Préat, Mohammad-Ali Shahbazi, Neha Shrestha, 2020, Journal of materials chemistry. B.

Intranasal immunization against influenza virus using polymeric particles.

V. Préat, D. Lemoine, M. Deschuyteneer, 1999, Journal of biomaterials science. Polymer edition.

Active enhancement methods for intra- and transdermal drug delivery: a review.

Damijan Miklavčič, Véronique Préat, Nataša Pavšelj, 2013 .

Aliphatic Polyesters: Particulate Vaccine Delivery

V. Préat, Joana M. Silva, H. Florindo, 2015 .

Immune system targeting by biodegradable nanoparticles for cancer vaccines.

Mafalda Videira, Rogério Gaspar, Véronique Préat, 2013, Journal of controlled release : official journal of the Controlled Release Society.

PLGA: From a classic drug carrier to a novel therapeutic activity contributor.

K. K. Chereddy, V. Préat, V. Payen, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Lactate stimulates angiogenesis and accelerates the healing of superficial and ischemic wounds in mice

O. Feron, V. Préat, P. Porporato, 2012, Angiogenesis.

Iron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translation.

V. Préat, F. Danhier, N. Schleich, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs.

J. Rolland, V. Préat, C. Jérôme, 2012, International journal of pharmaceutics.

Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide).

V. Préat, P. Maincent, C. François, 1996, Biomaterials.

Validation of subcutaneous microdialysis sampling for pharmacokinetic studies of flurbiprofen in the rat.

V. Préat, R. Verbeeck, F. Mathy, 2001, Journal of pharmaceutical sciences.

Oral delivery of non‐viral nucleic acid‐based therapeutics ‐ do we have the guts for this?

V. Préat, C. O’Driscoll, A. Bernkop‐Schnürch, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.

V. Préat, F. Danhier, B. Gallez, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Hollow Microneedle Arrays for Intradermal Drug Delivery and DNA Electroporation

Damijan Miklavcic, Natasa Pavselj, Gaëlle Vandermeulen, 2010, The Journal of Membrane Biology.

Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment

V. Préat, F. Danhier, Lakshmi Pallavi Ganipineni, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.

M. Brewster, V. Préat, F. Danhier, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Patterns of ligand binding to normal, regenerating, preneoplastic, and neoplastic rat hepatocytes.

V. Préat, E. Farber, L. Harris, 1987, Cancer research.

Decrease in Membrane-potential During Rat Hepatocarcinogenesis

M. Roberfroid, N. Delzenne, V. Préat, 1987 .

Changes in nucleolar transcriptional activity and nuclear DNA content during the first steps of rat hepatocarcinogenesis.

P. Castelain, A. Deleener, M. Kirsch‐Volders, 1987, Carcinogenesis.

Phenobarbital as a promoter in the initiation/selection process of experimental rat hepatocarcinogenesis.

M. Roberfroid, V. Préat, H. Taper, 1983, Carcinogenesis.

On glioblastoma and the search for a cure: where do we stand?

V. Préat, A. des Rieux, F. Danhier, 2017, Cellular and Molecular Life Sciences.

Coadministration of a Plasmid Encoding HIV-1 Gag Enhances the Efficacy of Cancer DNA Vaccines.

G. Vandermeulen, V. Préat, J. Grooten, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Immunotherapy for glioblastoma: the promise of combination strategies

V. Préat, A. Malfanti, Mathilde Bausart, 2022, Journal of experimental & clinical cancer research : CR.

Post‐resection treatment of glioblastoma with an injectable nanomedicine‐loaded photopolymerizable hydrogel induces long‐term survival

V. Préat, A. Jankovski, F. Danhier, 2018, International journal of pharmaceutics.

Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma.

V. Préat, G. Bastiat, K. Vanvarenberg, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

G. Vandermeulen, V. Préat, Alessandra Lopes, 2019, Journal of experimental & clinical cancer research : CR.

Nanocarrier-based drug combination therapy for glioblastoma

R. Schiffelers, V. Préat, Mengnan Zhao, 2020, Theranostics.

Novel strategy for oral peptide delivery in incretin-based diabetes treatment

Patrice D Cani, V. Préat, A. Beloqui, 2019, Gut.

The therapeutic contribution of nanomedicine to treat neurodegenerative diseases via neural stem cell differentiation.

V. Préat, A. des Rieux, P. Saulnier, 2017, Biomaterials.

Ear Pinna : a privileged DNA electroporation site for inducing strong Th1 immune responses

D. Scherman, G. Vandermeulen, V. Préat, 2009 .

Retinoic acid-loaded NFL-lipid nanocapsules promote oligodendrogenesis in focal white matter lesion.

V. Préat, A. des Rieux, P. Saulnier, 2019, Biomaterials.

The influence of phenobarbital and butylated hydroxytoluene on the ploidy rate in rat hepatocarcinogenesis.

P. Castelain, A. Deleener, M. Kirsch‐Volders, 1988, Carcinogenesis.

Cytogenetic and genetic alterations during hepatocarcinogenesis

P. Castelain, A. Deleener, M. Kirsch‐Volders, 1988 .

Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis.

M. Roberfroid, V. Préat, H. Taper, 1986, Carcinogenesis.

Influence of the nature and the dose of the initiator on the development of premalignant and malignant lesions in rat hepatocarcinogenesis.

M Roberfroid, M. Roberfroid, V. Préat, 1986, Teratogenesis, carcinogenesis, and mutagenesis.

Combined nanomedicines targeting colorectal cancer stem cells and cancer cells.

A. Puisieux, V. Préat, F. Fauvet, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Immunomodulation against microbial pathogens through dendritic cells

Liana C. Silva, V. Préat, R. Gaspar, 2013 .

Modulation of Liver Carcinogenesis by Surgery

M. Roberfroid, V. Préat, J. Pector, 1988 .

Modulating Factors of Hepatocarcinogenesis

N. Delzenne, V. Préat, 1987 .

An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers.

V. Préat, A. Beloqui, N. Shrestha, 2021, Advanced drug delivery reviews.

Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: Higher efficiency of the recombinant disintegrin domain of ADAM 15.

L. Mir, G. Vandermeulen, V. Préat, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Potentiation of radiotherapy by a localized antiangiogenic gene therapy.

V. Grégoire, V. Préat, F. Danhier, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Nanomedicine: A Useful Tool against Glioma Stem Cells

V. Préat, C. Bastiancich, E. Bozzato, 2020, Cancers.

Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing.

Robert E. W. Hancock, Gaëlle Vandermeulen, Véronique Préat, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin.

D Miklavcic, E Neumann, M Cemazar, 2008, Human gene therapy.

Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation.

V. Préat, R. Vanbever, S. Montmayeur, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Reformulating cyclosporine A (CsA): More than just a life cycle management strategy.

V. Préat, A. Beloqui, M. R. Kumar, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Solvent-free protamine nanocapsules as carriers for mucosal delivery of therapeutics

V. Préat, M. Alonso, N. Csaba, 2017 .

Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin

V. Préat, J. Ketelslegers, D. Lemoine, 1994 .

Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma

V. Préat, C. Jérôme, R. Riva, 2019, Journal of drug targeting.

Comparison of particle sizing techniques in the case of inhalation dry powders.

V. Préat, C. Lombry, R. Vanbever, 2001, Journal of pharmaceutical sciences.

Targeting Inflammatory Bowel Diseases by Nanocarriers Loaded with Small and Biopharmaceutical Anti-Inflammatory Drugs.

V. Préat, A. Beloqui, R. Coco, 2016, Current pharmaceutical design.

Influence of the duration and the delay of administration of phenobarbital on its modulating effect on rat hepatocarcinogenesis.

M. Roberfroid, V. Préat, H. Taper, 1987, Carcinogenesis.

Poly(lactic acid)-based particulate systems are promising tools for immune modulation.

V. Préat, L. Graça, Joana M. Silva, 2017, Acta biomaterialia.

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

G. Vandermeulen, V. Préat, Alessandra Lopes, 2019, Journal of Experimental & Clinical Cancer Research.

Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier.

V. Préat, A. des Rieux, A. Beloqui, 2016, Advanced drug delivery reviews.

Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.

V. Préat, F. Danhier, P. Danhier, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation.

Véronique Préat, Ronit Satchi-Fainaro, Vanessa Sainz, 2017, Seminars in immunology.

Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.

V. Préat, K. Vanvarenberg, G. Rodella, 2023, Biomaterials.

Multifunctional Self-Assembled Peptide Hydrogels for Biomedical Applications

V. Préat, M. Shahbazi, N. Shrestha, 2023, Polymers.

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma

G. Vandermeulen, V. Préat, K. Vanvarenberg, 2018, Scientific Reports.

Rationally Designed Drug Delivery Systems For The Local Treatment Of Resected Glioblastoma.

V. Préat, R. Rahman, C. Bastiancich, 2021, Advanced drug delivery reviews.

Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma

V. Préat, Mingchao Wang, A. Malfanti, 2022, Pharmaceutics.

Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment

V. Préat, G. Bastiat, F. Danhier, 2019, International journal of pharmaceutics.

Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.

V. Préat, A. des Rieux, K. Vanvarenberg, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Intramuscular electroporation of a P1A-encoding plasmid vaccine delays P815 mastocytoma growth.

C. Uyttenhove, G. Vandermeulen, V. Préat, 2014, Bioelectrochemistry.

Intramuscular electroporation of a P 1 A-encoding plasmid vaccine delays P 815 mastocytoma growth

C. Uyttenhove, G. Vandermeulen, V. Préat, 2014 .

In vivo Tolerance Assessment of Skin after Insertion of Subcutaneous and Cutaneous Microdialysis Probes in the Rat

P. Clarys, A. Barel, V. Préat, 2003, Skin Pharmacology and Physiology.

High-Throughput Screening of Excipients Intended to Prevent Antigen Aggregation at Air-Liquid Interface

Dominique Lemoine, Véronique Préat, Sébastien Dasnoy, 2011, Pharmaceutical Research.

Macrophage Activation by Polymeric Nanoparticles of Polyalkylcyanoacrylates: Activity Against Intracellular Leishmania donovani Associated with Hydrogen Peroxide Production

Rogério Gaspar, Fred R. Opperdoes, F. Opperdoes, 1992, Pharmaceutical Research.

Study of the percutaneous penetration of flurbiprofen by cutaneous and subcutaneous microdialysis after iontophoretic delivery in rat.

V. Préat, C. Lombry, R. Verbeeck, 2005, Journal of pharmaceutical sciences.

Injectable alginate hydrogel loaded with GDNF promotes functional recovery in a hemisection model of spinal cord injury.

V. Préat, A. des Rieux, A. Jankovski, 2013, International journal of pharmaceutics.

DNA transfer in the skin

G. Vandermeulen, V. Préat, Liévin Daugimont, 2008 .

Topical delivery of nucleic acids in the skin

V. Préat, Nathalie Dujardin, 2001 .

Use of Staby® technology for development and production of DNA vaccines free of antibiotic resistance gene

H. Nauwynck, G. Vandermeulen, V. Préat, 2013, Human vaccines & immunotherapeutics.

Ascorbyl-dipalmitate-stabilised nanoemulsions as a potential localised treatment of inflammatory bowel diseases.

M. V. Lozano, M. J. Santander-Ortega, V. Préat, 2020, International journal of pharmaceutics.

Curcuma longa Extract Associated with White Pepper Lessens High Fat Diet-Induced Inflammation in Subcutaneous Adipose Tissue

Patrice D Cani, A. Neyrinck, N. Delzenne, 2013, PloS one.

Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel.

Christine Jérôme, Véronique Préat, Jacqueline Marchand-Brynaert, 2009, Journal of controlled release : official journal of the Controlled Release Society.

In vivo testing of orally delivered nanoparticles

V. Préat, N. Shrestha, 2020 .

Transdermal iontophoresis of fentanyl: delivery and mechanistic analysis

V. Préat, S. Thysman, C. Tasset, 1994 .

Localization of a FITC-Labeled Phosphorothioate Oligodeoxynucleotide in the Skin After Topical Delivery by Iontophoresis and Electroporation

V. Préat, V. Regnier, 1998, Pharmaceutical Research.

In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery.

D. Miklavčič, T. Kosjek, V. Préat, 2013, Journal of controlled release : official journal of the Controlled Release Society.

A Numerical Model of Skin Electropermeabilization Based on In Vivo Experiments

Damijan Miklavčič, Nataša Pavšelj, D. Miklavčič, 2007, Annals of Biomedical Engineering.

The type and composition of alginate and hyaluronic-based hydrogels influence the viability of stem cells of the apical papilla.

C. Dupont-Gillain, V. Préat, A. des Rieux, 2014, Dental materials : official publication of the Academy of Dental Materials.

Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy.

V. Préat, F. Danhier, B. Ucakar, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Cationic and anionic lipoplexes inhibit gene transfection by electroporation in vivo

D. Scherman, M. Bureau, M. Rols, 2010, The journal of gene medicine.

In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model.

Mafalda Videira, Gaëlle Vandermeulen, Véronique Préat, 2015, Journal of controlled release : official journal of the Controlled Release Society.

The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers.

P. Artursson, Å. Keita, V. Préat, 2018, Nanoscale.

An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells.

Yves-Jacques Schneider, Véronique Préat, Ivan Théate, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier.

M. Brewster, Y. Schneider, V. Préat, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Chitosan-based siRNA delivery systems.

Héloïse Ragelle, Gaëlle Vandermeulen, Véronique Préat, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method.

Héloïse Ragelle, Véronique Préat, Jacqueline Marchand-Brynaert, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Layer-by-Layer Nanoarchitectonics Using Protein-Polyelectrolyte Complexes toward a Generalizable Tool for Protein Surface Immobilization.

C. Dupont-Gillain, V. Préat, O. Cornu, 2022, Langmuir : the ACS journal of surfaces and colloids.

Strategies to improve the EPR effect for the delivery of anti-cancer nanomedicines

V. Préat, F. Danhier, 2015 .

Electron Paramagnetic Resonance Highlights That the Oxygen Effect Contributes to the Radiosensitizing Effect of Paclitaxel

V. Préat, F. Danhier, B. Ucakar, 2012, PloS one.

Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDSs) for senicapoc.

V. Préat, A. Beloqui, B. Ucakar, 2020, International journal of pharmaceutics.

Acylated and unacylated ghrelin binding to membranes and to ghrelin receptor: towards a better understanding of the underlying mechanisms.

P. Absil, R. Brasseur, L. Lins, 2010, Biochimica et biophysica acta.

Partial hepatectomy of rats ten weeks before carcinogen administration can enhance liver carcinogenesis: preliminary observations.

H. Bartsch, M. Roberfroid, V. Préat, 1988, Carcinogenesis.

Nanosuspension for the delivery of a poorly soluble anti-cancer kinase inhibitor.

M. Brewster, V. Préat, F. Danhier, 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures

Robert Langer, Véronique Préat, Héloïse Ragelle, 2017, Expert opinion on drug delivery.

Hybrid Semiparametric Modeling: A Modular Process Systems Engineering Approach for the Integration of Available Knowledge Sources

Oscar Andrés Prado-Rubio, Mark J. Willis, Véronique Préat, 2019 .

Biodegradable Self-Assembling PEG-Copolymer as Vehicle for Poorly Water-Soluble Drugs

J. Rosenblatt, M. Brewster, V. Préat, 2004, Pharmaceutical Research.

Lactate stimulates angiogenesis and accelerates the healing of superficial and ischemic wounds in mice

V. Préat, P. Porporato, J. Thissen, 2012, Angiogenesis.

Intestinal uptake and biodistribution of novel polymeric micelles after oral administration.

M. Brewster, V. Préat, L. van Beijsterveldt, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation.

D. Arango, S. Schwartz, V. Préat, 2022, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Optimisation of intradermal DNA electrotransfer for immunisation.

Gaëlle Vandermeulen, Véronique Préat, Daniel Scherman, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma

G. Vandermeulen, V. Préat, K. Vanvarenberg, 2017, Molecular therapy. Nucleic acids.

pFARs, Plasmids free of antibiotic resistance markers, display high‐level transgene expression in muscle, skin and tumour cells

D. Scherman, G. Vandermeulen, V. Préat, 2010, The journal of gene medicine.

Polyelectrolyte complex nanoparticles from chitosan and poly(acrylic acid) and Polystyrene‐block‐poly(acrylic acid)

J. Rolland, V. Préat, J. Gohy, 2012 .

Polymeric nanoparticles as delivery system for influenza virus glycoproteins.

V. Préat, V Préat, D. Lemoine, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Synthesis and In Vitro Evaluation of Polyethylene Glycol-Paclitaxel Conjugates for Lung Cancer Therapy

C. Alexander, V. Préat, R. Vanbever, 2016, Pharmaceutical Research.

Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models.

F. Franconi, L. Lemaire, V. Préat, 2018, Nanomedicine.

Self-assembling PEG-p(CL-co-TMC) copolymers for oral delivery of poorly water-soluble drugs: a case study with risperidone.

X. Langlois, M. Brewster, V. Préat, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression”

V. Préat, B. Manshian, B. Gallez, 2023, Cancers.

Spontaneously self-assembled micelles from poly(ethylene glycol)-b-poly(epsilon-caprolactone-co-trimethylene carbonate) for drug solubilization.

M. Brewster, V. Préat, L. Rouxhet, 2008, Die Pharmazie.

New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.

Gaëlle Vandermeulen, Véronique Préat, Daniel Scherman, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Combination of local immunogenic cell death-inducing chemotherapy and DNA vaccine increases the survival of glioblastoma-bearing mice.

V. Préat, K. Vanvarenberg, B. Ucakar, 2023, Nanomedicine : nanotechnology, biology, and medicine.

Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting.

V. Préat, B. Sarmento, J. Aylott, 2023, Small.

Transdermal Delivery of Fentanyl by Electroporation I. Influence of Electrical Factors

Véronique Préat, V. Préat, R. Vanbever, 1996, Pharmaceutical Research.

Factors affecting transdermal delivery of metoprolol by electroporation

V. Préat, R. Vanbever, 1995 .

Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen

L. E. Pedersen, G. Vandermeulen, V. Préat, 2015, PloS one.

Hyaluronic acid-antigens conjugates trigger potent immune response in both prophylactic and therapeutic immunization in a melanoma model

V. Préat, K. Vanvarenberg, B. Ucakar, 2023, Drug Delivery and Translational Research.

Vascular endothelial growth factor-loaded injectable hydrogel enhances plasticity in the injured spinal cord.

P. Carmeliet, V. Préat, A. des Rieux, 2014, Journal of biomedical materials research. Part A.

Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.

V. Préat, G. Bastiat, Umer Farooq, 2023, Biomaterials advances.

Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization and in vitro anticancer activity CHAPTER IV – SELF-ASSEMBLING DOXORUBICIN-TOCOPHEROL SUCCINATE PRODRUG AS A NEW DRUG DELIVERY SYSTEM: SYNTHESIS, CHARACTERIZATION AND IN VITRO ANTICANCE

U. Schubert, V. Préat, S. Hoeppener, 2013 .

In vitro identification of targeting ligands of human M cells by phage display.

Y. Schneider, V. Préat, C. Jérôme, 2010, International journal of pharmaceutics.

VEGF-loaded injectable hydrogel enhances plasticity in the injured spinal cord

P. Carmeliet, V. Préat, C. Bouzin, 2013 .

A novel, smaller scaffold for Affitins: Showcase with binders specific for EpCAM

V. Préat, F. Pecorari, G. Béhar, 2018, Biotechnology and bioengineering.

Passive diffusion of polymeric surfactants across lipid bilayers.

M. Brewster, V. Préat, M. Noppe, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Transdermal delivery of timolol by electroporation through human skin.

Véronique Préat, V. Préat, A. Denet, 2003, Journal of controlled release : official journal of the Controlled Release Society.

In vivo assessment of skin electroporation using square wave pulses.

Peter Clarys, Nathalie Dujardin, Y. Kalia, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Transdermal Delivery of Timolol and Atenolol Using Electroporation and Iontophoresis in Combination: A Mechanistic Approach

Bernard Ucakar, Véronique Préat, V. Préat, 2003, Pharmaceutical Research.

LOCAL TRANSPORT REGIONS (LTRS) IN HUMAN STRATUM CORNEUM DUE TO LONG AND SHORT 'HIGH VOLTAGE' PULSES

James C. Weaver, Véronique Préat, Uwe Pliquett, 1998 .

Macromolecules as Novel Transdermal Transport Enhancers for Skin Electroporation

M. Prausnitz, V. Préat, R. Vanbever, 1997, Pharmaceutical Research.

Nanostructures overcoming the skin barrier: drug delivery strategies

V. Préat, N. Schleich, Nathalie Schleich, 2012 .

Electrotransfer parameters as a tool for controlled and targeted gene expression in skin.

Simona Kranjc, Gregor Sersa, Gaëlle Vandermeulen, 2016, Molecular therapy. Nucleic acids.

Intradermal DNA vaccination combined with dual CTLA-4 and PD-1 blockade provides robust tumor immunity in murine melanoma

G. Vandermeulen, V. Préat, M. Čemažar, 2019, PloS one.

Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI

V. Préat, K. Vanvarenberg, B. Ucakar, 2023, Biomedicines.

Noninvasive investigation of human skin after in vivo iontophoresis.

V. Préat, D. Van Neste, S. Thysman, 1995, Skin pharmacology : the official journal of the Skin Pharmacology Society.

Factors affecting iontophoretic mobility of metoprolol.

V. Préat, M. Roland, S. Thysman, 1992, Journal of pharmaceutical sciences.

Laser Doppler evaluation of skin reaction in volunteers after histamine iontophoresis

V. Préat, A. Jadoul, D. Neste, 1995 .

Thiol-ene Reaction: An Efficient Tool to Design Lipophilic Polyphosphoesters for Drug Delivery Systems

V. Préat, C. Jérôme, R. Riva, 2021, Molecules.

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma

G. Vandermeulen, V. Préat, K. Vanvarenberg, 2018, Scientific Reports.

Tumor Targeting by RGD-Grafted PLGA-Based Nanotheranostics Loaded with Paclitaxel and Superparamagnetic Iron Oxides

S. Laurent, V. Préat, C. Jérôme, 2015 .

Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.

V. Préat, A. des Rieux, M. Garinot, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Immune system targeting by biodegradable nanoparticles for cancer vaccines.

V. Préat, R. Gaspar, M. Videira, 2013, Journal of Controlled Release.

Vascular endothelial growth factor-loaded injectable hydrogel enhances plasticity in the injured spinal cord.

P. Carmeliet, V. Préat, A. des Rieux, 2014, Journal of Biomedical Materials Research. Part A.

Acylated and unacylated ghrelin binding to membranes and to ghrelin receptor: towards a better understanding of the underlying mechanisms.

P. Absil, R. Brasseur, L. Lins, 2010, Biochimica et biophysica acta.

Validation of a method for the quantitation of ghrelin and unacylated ghrelin by HPLC.

Philippe Hubert, Eric Rozet, Bernard Ucakar, 2010, Journal of pharmaceutical and biomedical analysis.

Chitosan-based siRNA delivery systems.

G. Vandermeulen, V. Préat, Héloïse Ragelle, 2013, Journal of controlled release : official journal of the Controlled Release Society.

In Vitro Lipolysis and Intestinal Transport of β-Arteether-Loaded Lipid-Based Drug Delivery Systems

E. Gaigneaux, V. Préat, P. Eloy, 2013, Pharmaceutical Research.

pFAR plasmids: New Eukaryotic Expression Vectors for Gene Therapy, devoid of Antibiotic Resistance Markers

D. Scherman, G. Vandermeulen, V. Préat, 2008 .

Nanostructured lipid carriers: Promising drug delivery systems for future clinics.

V. Préat, A. Almeida, A. Beloqui, 2016, Nanomedicine : nanotechnology, biology, and medicine.

Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.

M. Brewster, V. Préat, F. Danhier, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Local delivery of doxorubicin prodrug via lipid nanocapsule-based hydrogel for the treatment of glioblastoma.

V. Préat, C. Bastiancich, Mingchao Wang, 2023, Drug delivery and translational research.

Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: Higher efficiency of the recombinant disintegrin domain of ADAM 15.

L. Mir, G. Vandermeulen, V. Préat, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging.

S. Laurent, R. Muller, V. Préat, 2013, International journal of pharmaceutics.

Evaluation of lipid‐based carrier systems and inclusion complexes of diethyldithiocarbamate–iron to trap nitric oxide in biological systems

V. Préat, B. Gallez, N. Charlier, 2006, Magnetic resonance in medicine.

Improvement of Lipid Detection in Mouse Brain and Human Uterine Tissue Sections Using In Situ Matrix Enhanced Secondary Ion Mass Spectrometry.

C. Dupont-Gillain, V. Préat, K. Vanvarenberg, 2023, Journal of the American Society for Mass Spectrometry.

Qualitative prediction of solubilization of highly hydrophobic drugs in block copolymer micelles.

M. Brewster, V. Préat, M. Dinguizli, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing.

R. Hancock, F. Jacobsen, K. K. Chereddy, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Polyelectrolyte complex nanoparticles from chitosan and poly(acrylic acid) and Polystyrene‐block‐poly(acrylic acid)

J. Rolland, V. Préat, J. Gohy, 2012 .

Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies.

V. Préat, A. Jadoul, Jadoul, 1999, Advanced drug delivery reviews.

Transdermal Delivery of Metoprolol by Electroporation

V. Préat, R. Vanbever, N. Lecouturier, 1994, Pharmaceutical Research.

Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.

V. Préat, A. des Rieux, K. Vanvarenberg, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Photosensitizer localization in amphiphilic block copolymers controls photodynamic therapy efficacy.

N. McClenaghan, V. Préat, J. Guigner, 2017, Nanoscale.

Gene electrotransfer into skin using noninvasive multi-electrode array for vaccination and wound healing.

G. Vandermeulen, V. Préat, M. Čemažar, 2017, Bioelectrochemistry.

Transdermal drug delivery by skin electroporation in the rat.

V. Préat, R. Vanbever, 2000, Methods in molecular medicine.

Electroperturbation of human stratum corneum fine structure by high voltage pulses: a freeze-fracture electron microscopy and differential thermal analysis study.

J. Bouwstra, H. Boddé, V. Préat, 1998, The journal of investigative dermatology. Symposium proceedings.